Columbia University and NYP announced today that Florence Irving and her late husband, Herbert Irving, have given $700 million to the two institutions to dramatically advance research and clinical programs for the treatment of cancer.
Dr. Naiyer Rizvi, director of thoracic oncology at CUMC, offers updates on immune checkpoint inhibitors in certain forms of lung cancers.
Columbia scientists have created new decoy drugs that can intercept the deceptive growth signals that cancer cells send out.
A study of the genomes of patients with a particularly aggressive form of non-Hodgkin’s lymphoma shows that many cases are driven by alterations in the JAK/STAT3 cell signaling pathway.
Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine is changing the face of cancer research.
Al final de los 1800, un cirujano…